HK Stock MarketDetailed Quotes

02367 GIANT BIOGENE

Watchlist
  • 51.600
  • -0.050-0.10%
Not Open Dec 16 16:08 CST
53.06BMarket Cap27.39P/E (TTM)

GIANT BIOGENE Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Assets
Current assets
Inventory
78.96%333.74M
9.00%200.44M
--186.49M
105.71%183.9M
38.26%89.39M
27.12%64.66M
--50.86M
Accounts receivable
115.25%195.92M
46.97%102.03M
--91.02M
5.76%69.42M
20.39%65.64M
215.89%54.52M
--17.26M
Related party payments receivable
----
----
----
----
----
-63.72%201.31M
--554.9M
Advance deposits and other receivables
23.78%94.47M
-38.47%53.84M
--76.32M
216.08%87.5M
271.07%27.68M
-54.20%7.46M
--16.29M
Cash and equivalents
193.06%4.56B
88.14%2.5B
--1.56B
-81.26%1.33B
1,831.19%7.1B
408.56%367.81M
--72.32M
Financial assets at fair value-current assets
22.57%1.5B
47.21%1.27B
--1.22B
456.51%865.97M
-90.20%155.61M
112.74%1.59B
--746.62M
Total current assets
113.35%6.69B
62.94%4.14B
--3.13B
-65.90%2.54B
225.79%7.44B
56.63%2.28B
--1.46B
Non-current assets
Property, plant and equipment
66.30%928.67M
35.01%663.47M
--558.42M
79.13%491.42M
14.13%274.34M
-7.10%240.36M
--258.72M
Investment property
----
----
----
----
-7.35%24.17M
--26.09M
----
Advance payment
-23.35%99.91M
188.32%117.91M
--130.34M
-41.78%40.9M
39.93%70.24M
98.16%50.2M
--25.33M
Associated company interest
--10.26M
----
----
----
----
----
----
Intangible assets
9.23%6.57M
8.98%7.36M
--6.02M
-11.15%6.75M
-13.48%7.6M
-4.06%8.78M
--9.15M
Deferred tax assets
-13.33%156K
-6.72%1.11M
--180K
-11.98%1.19M
9.92%1.35M
-71.10%1.23M
--4.26M
Total non-current assets
47.00%1.09B
39.55%838M
--743.13M
37.45%600.49M
19.04%436.89M
8.36%367.01M
--338.68M
Total assets
100.63%7.78B
58.47%4.97B
--3.88B
-60.17%3.14B
197.17%7.88B
47.53%2.65B
--1.8B
Liabilities
Current liabilities
Accounts payable
359.28%337.11M
143.55%133.11M
--73.4M
131.46%54.65M
-26.09%23.61M
40.24%31.95M
--22.78M
Tax payable
24.33%97.67M
55.59%116.72M
--78.56M
5.14%75.02M
-50.53%71.36M
17.39%144.23M
--122.87M
Dividend payable
----
----
----
----
-80.66%367.46M
378.59%1.9B
--397M
Other payables and accrued expenses
649.06%1.27B
77.40%241.97M
--168.91M
-97.86%136.4M
6,679.36%6.36B
20.73%93.86M
--77.74M
Financial lease liabilities-current liabilities
51.88%1.37M
77.41%1.56M
--902K
--881K
----
----
----
Deferred income-current liabilities
16.42%1.5M
0.00%1.5M
--1.29M
0.20%1.5M
-44.05%1.5M
65.49%2.68M
--1.62M
Total current liabilities
422.14%1.76B
88.89%530.61M
--336.24M
-95.90%280.91M
214.78%6.84B
247.24%2.17B
--626.05M
Net current assets
76.25%4.93B
59.71%3.6B
--2.8B
277.22%2.26B
442.86%598.28M
-86.76%110.21M
--832.2M
Total assets less current liabilities
70.11%6.02B
55.48%4.44B
--3.54B
176.03%2.86B
116.92%1.04B
-59.24%477.22M
--1.17B
Non-current liabilities
Financial lease liabilities-non-current liabilities
-92.80%87K
-31.61%1.17M
--1.21M
--1.71M
----
----
----
Deferred tax liability
517.49%31.2M
12,474.44%50.68M
--5.05M
-47.73%403K
-37.92%771K
10,250.00%1.24M
--12K
Deferred income-non-current liabilities
4.58%18.86M
7.68%19.58M
--18.03M
3.38%18.18M
-2.16%17.58M
-7.46%17.97M
--19.42M
Total non-current liabilities
106.41%50.15M
252.03%71.42M
--24.29M
10.53%20.29M
-4.48%18.36M
-1.13%19.22M
--19.43M
Total liabilities
400.87%1.81B
99.88%602.03M
--360.53M
-95.61%301.19M
212.86%6.86B
239.76%2.19B
--645.49M
Total assets less total liabilities
69.86%5.97B
54.07%4.37B
--3.52B
179.01%2.84B
122.01%1.02B
-60.22%458M
--1.15B
Total equity and non-current liabilities
70.11%6.02B
55.48%4.44B
--3.54B
176.03%2.86B
116.92%1.04B
-59.24%477.22M
--1.17B
Equity
Share capital
3.17%65K
0.00%63K
--63K
8.62%63K
--58K
----
----
Other equity instruments
----
----
----
----
--23K
----
----
Reserve
70.05%5.97B
53.95%4.36B
--3.51B
178.68%2.83B
121.99%1.02B
-60.09%458M
--1.15B
Shareholders' Equity
70.05%5.97B
53.95%4.36B
--3.51B
178.66%2.83B
122.01%1.02B
-60.09%458M
--1.15B
Non-controlling interest
-29.02%4.72M
150.21%8.91M
--6.64M
--3.56M
----
----
--3.75M
Total equity
69.86%5.97B
54.07%4.37B
--3.52B
179.01%2.84B
122.01%1.02B
-60.22%458M
--1.15B
Total equity and total liabilities
100.63%7.78B
58.47%4.97B
--3.88B
-60.17%3.14B
197.17%7.88B
47.53%2.65B
--1.8B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
Ernst & Young
Ernst & Young
Ernst & Young
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Assets
Current assets
Inventory 78.96%333.74M9.00%200.44M--186.49M105.71%183.9M38.26%89.39M27.12%64.66M--50.86M
Accounts receivable 115.25%195.92M46.97%102.03M--91.02M5.76%69.42M20.39%65.64M215.89%54.52M--17.26M
Related party payments receivable ---------------------63.72%201.31M--554.9M
Advance deposits and other receivables 23.78%94.47M-38.47%53.84M--76.32M216.08%87.5M271.07%27.68M-54.20%7.46M--16.29M
Cash and equivalents 193.06%4.56B88.14%2.5B--1.56B-81.26%1.33B1,831.19%7.1B408.56%367.81M--72.32M
Financial assets at fair value-current assets 22.57%1.5B47.21%1.27B--1.22B456.51%865.97M-90.20%155.61M112.74%1.59B--746.62M
Total current assets 113.35%6.69B62.94%4.14B--3.13B-65.90%2.54B225.79%7.44B56.63%2.28B--1.46B
Non-current assets
Property, plant and equipment 66.30%928.67M35.01%663.47M--558.42M79.13%491.42M14.13%274.34M-7.10%240.36M--258.72M
Investment property -----------------7.35%24.17M--26.09M----
Advance payment -23.35%99.91M188.32%117.91M--130.34M-41.78%40.9M39.93%70.24M98.16%50.2M--25.33M
Associated company interest --10.26M------------------------
Intangible assets 9.23%6.57M8.98%7.36M--6.02M-11.15%6.75M-13.48%7.6M-4.06%8.78M--9.15M
Deferred tax assets -13.33%156K-6.72%1.11M--180K-11.98%1.19M9.92%1.35M-71.10%1.23M--4.26M
Total non-current assets 47.00%1.09B39.55%838M--743.13M37.45%600.49M19.04%436.89M8.36%367.01M--338.68M
Total assets 100.63%7.78B58.47%4.97B--3.88B-60.17%3.14B197.17%7.88B47.53%2.65B--1.8B
Liabilities
Current liabilities
Accounts payable 359.28%337.11M143.55%133.11M--73.4M131.46%54.65M-26.09%23.61M40.24%31.95M--22.78M
Tax payable 24.33%97.67M55.59%116.72M--78.56M5.14%75.02M-50.53%71.36M17.39%144.23M--122.87M
Dividend payable -----------------80.66%367.46M378.59%1.9B--397M
Other payables and accrued expenses 649.06%1.27B77.40%241.97M--168.91M-97.86%136.4M6,679.36%6.36B20.73%93.86M--77.74M
Financial lease liabilities-current liabilities 51.88%1.37M77.41%1.56M--902K--881K------------
Deferred income-current liabilities 16.42%1.5M0.00%1.5M--1.29M0.20%1.5M-44.05%1.5M65.49%2.68M--1.62M
Total current liabilities 422.14%1.76B88.89%530.61M--336.24M-95.90%280.91M214.78%6.84B247.24%2.17B--626.05M
Net current assets 76.25%4.93B59.71%3.6B--2.8B277.22%2.26B442.86%598.28M-86.76%110.21M--832.2M
Total assets less current liabilities 70.11%6.02B55.48%4.44B--3.54B176.03%2.86B116.92%1.04B-59.24%477.22M--1.17B
Non-current liabilities
Financial lease liabilities-non-current liabilities -92.80%87K-31.61%1.17M--1.21M--1.71M------------
Deferred tax liability 517.49%31.2M12,474.44%50.68M--5.05M-47.73%403K-37.92%771K10,250.00%1.24M--12K
Deferred income-non-current liabilities 4.58%18.86M7.68%19.58M--18.03M3.38%18.18M-2.16%17.58M-7.46%17.97M--19.42M
Total non-current liabilities 106.41%50.15M252.03%71.42M--24.29M10.53%20.29M-4.48%18.36M-1.13%19.22M--19.43M
Total liabilities 400.87%1.81B99.88%602.03M--360.53M-95.61%301.19M212.86%6.86B239.76%2.19B--645.49M
Total assets less total liabilities 69.86%5.97B54.07%4.37B--3.52B179.01%2.84B122.01%1.02B-60.22%458M--1.15B
Total equity and non-current liabilities 70.11%6.02B55.48%4.44B--3.54B176.03%2.86B116.92%1.04B-59.24%477.22M--1.17B
Equity
Share capital 3.17%65K0.00%63K--63K8.62%63K--58K--------
Other equity instruments ------------------23K--------
Reserve 70.05%5.97B53.95%4.36B--3.51B178.68%2.83B121.99%1.02B-60.09%458M--1.15B
Shareholders' Equity 70.05%5.97B53.95%4.36B--3.51B178.66%2.83B122.01%1.02B-60.09%458M--1.15B
Non-controlling interest -29.02%4.72M150.21%8.91M--6.64M--3.56M----------3.75M
Total equity 69.86%5.97B54.07%4.37B--3.52B179.01%2.84B122.01%1.02B-60.22%458M--1.15B
Total equity and total liabilities 100.63%7.78B58.47%4.97B--3.88B-60.17%3.14B197.17%7.88B47.53%2.65B--1.8B
Currency Unit CNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified Opinion
Auditor --Ernst & Young--Ernst & YoungErnst & YoungErnst & YoungErnst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Price
% Chg

No Data

Investment Theme Aesthetic Medicine
Aesthetic Medicine
Intraday-1.16%